Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Vasilios Tzilas
Observed names:
Tzilas, Vasilios,
V Tzilas,
V. TZILAS,
V. Tzilas,
V., Tzilas,
Vasilis Tzilas,
Vassilios Tzilas,
Vassilis Tzilas
show all 8
Institutions:
National and Kapodistrian University of Athens,
University General Hospital Attikon
Observed institutions:
Democritus University of Thrace,
National and Kapodistrian University of Athens,
Athens Medical Center,
University General Hospital Attikon,
Sotiria General Hospital
ORCID:
0000-0002-7030-6166
Observed ORCID:
0000-0002-7030-6166
OpenAlex ID:
A5025653263
Common Pathogenic Mechanisms Between Idiopathic Pulmonary Fibrosis and Lung Cancer
2019
·
Argyris Tzouvelekis
, Georgia Gomatou
, et al.
·
CHEST Journal
·
176
Lung cancer in patients with idiopathic pulmonary fibrosis
2017
·
Theodoros Karampitsakos
, Vasilios Tzilas
, et al.
·
Pulmonary Pharmacology & Therapeutics
·
171
Patients with IPF and lung cancer: diagnosis and management
2017
·
Argyris Tzouvelekis
, Paolo Spagnolo
, et al.
·
The Lancet Respiratory Medicine
·
100
Vitamin D prevents experimental lung fibrosis and predicts survival in patients with idiopathic pulmonary fibrosis
2019
·
Vasilios Tzilas
, Evangelos Bouros
, et al.
·
Pulmonary Pharmacology & Therapeutics
·
92
Immune Checkpoint Inhibitor-Related Pneumonitis
2020
·
Georgia Gomatou
, Vasilios Tzilas
, et al.
·
Respiration
·
75
Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis
2021
·
Theodoros Karampitsakos
, Sebastiano Torrisi
, et al.
·
Respiratory Research
·
67
PDF
Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study
2020
·
Katerina Antoniou
, Katerina Markopoulou
, et al.
·
ERJ Open Research
·
62
PDF
Safety and efficacy of nintedanib in idiopathic pulmonary fibrosis: A real-life observational study in Greece
2018
·
Argyrios Tzouvelekis
, Theodoros Karampitsakos
, et al.
·
Pulmonary Pharmacology & Therapeutics
·
59
Metabolic Disorders in Chronic Lung Diseases
2018
·
Ourania Papaioannou
, Theodoros Karampitsakos
, et al.
·
Frontiers in Medicine
·
57
PDF
Impact of Depression on Patients With Idiopathic Pulmonary Fibrosis
2020
·
Argyris Tzouvelekis
, Theodoros Karampitsakos
, et al.
·
Frontiers in Medicine
·
54
PDF
Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study in Greece
2019
·
Argyris Tzouvelekis
, Theodoros Karampitsakos
, et al.
·
Pulmonary Pharmacology & Therapeutics
·
51
Safety and efficacy of pirfenidone in severe Idiopathic Pulmonary Fibrosis: A real-world observational study
2017
·
Argyrios Tzouvelekis
, Paschalis Ntolios
, et al.
·
Pulmonary Pharmacology & Therapeutics
·
47
Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
2017
·
Argyrios Tzouvelekis
, Theodoros Karampitsakos
, et al.
·
Frontiers in Medicine
·
44
PDF
Towards the adoption of quantitative computed tomography in the management of interstitial lung disease
2024
·
Simon L.F. Walsh
, Jan De Backer
, et al.
·
European Respiratory Review
·
43
PDF
Diagnostic value of BAL lymphocytosis in patients with indeterminate for usual interstitial pneumonia imaging pattern
2019
·
Vasilios Tzilas
, Argyrios Tzouvelekis
, et al.
·
European Respiratory Journal
·
42
PDF
2022 update on clinical practice guidelines for idiopathic pulmonary fibrosis and progressive pulmonary fibrosis
2022
·
Vasilios Tzilas
, Argyrios Tzouvelekis
, et al.
·
The Lancet Respiratory Medicine
·
40
Clinical experience with antifibrotics in fibrotic hypersensitivity pneumonitis: a 3-year real-life observational study
2020
·
Vasilios Tzilas
, Argyris Tzouvelekis
, et al.
·
ERJ Open Research
·
33
PDF
Intravenous Immunoglobulin for the Treatment of COVID-19: A Promising Tool
2020
·
Vasilios Tzilas
, Effrosyni Manali
, et al.
·
Respiration
·
28
PDF
Clinical features and outcomes of patients with myositis associated-interstitial lung disease
2023
·
Theodoros Karampitsakos
, Vasilios Tzilas
, et al.
·
Frontiers in Medicine
·
19
PDF
Management of Patients with Interstitial Lung Disease in the Midst of the COVID-19 Pandemic
2020
·
Katerina M. Antoniou
, Ganesh Raghu
, et al.
·
Respiration
·
19
PDF
The Role of Microbiome and Virome in Idiopathic Pulmonary Fibrosis
2021
·
Paschalis Ntolios
, Vassilios Tzilas
, et al.
·
Biomedicines
·
18
PDF
Early COVID-19 lockdown in Greece and idiopathic pulmonary fibrosis: a beneficial “impact” beyond any expectation
2020
·
Spyros A. Papiris
, Demosthenes Bouros
, et al.
·
European Respiratory Journal
·
18
PDF
Diagnostic and prognostic challenges in Idiopathic Pulmonary Fibrosis: A patient's “Q and A” approach
2016
·
Argyris Tzouvelekis
, Vasilios Tzilas
, et al.
·
Pulmonary Pharmacology & Therapeutics
·
18
Diagnosis of Idiopathic Pulmonary Fibrosis “Pragmatic Challenges in Clinical Practice”
2017
·
Vasilios Tzilas
, Argyris Tzouvelekis
, et al.
·
Frontiers in Medicine
·
17
PDF
Prognostic Factors in Idiopathic Pulmonary Fibrosis
2009
·
Vasilios Tzilas
, Aspasia Koti
, et al.
·
The American Journal of the Medical Sciences
·
17
PDF
Show more works
View as search
Works count:
141
Citation count:
1,678
H-index:
19
I10-index:
30
Year
Topic
Type
